Pancreatic cancer often arises from microscopic non-invasive epithelial proliferations in the pancreatic ducts and are accompanied by driver gene mutations including KRAS, TP53, SMAD4 and CDKN21. This evidence concerns the gene KRAS and pancreatic neoplasm.